Rockpool has made a strategic investment in TalarMade, a leading provider of medical devices and clinical services, to support its expansion plans within the growing UK healthcare market.
Target Information
Rockpool has invested in TalarMade, a rapidly growing provider of medical devices and clinical services. TalarMade specializes in orthotics and pressure care products, catering to both the NHS and private healthcare providers in various settings including orthotics, podiatry, physiotherapy, and occupational therapy.
Established in 2002 by Chairman Bernie Crewdson, TalarMade has emerged as a leader in proprietary medical devices and a reliable distributor of specialist brands. The company boasts a diverse portfolio of orthotic and pressure care solutions, developed by in-house clinicians with a strong emphasis on evidence-based design, regulatory compliance, and improving patient outcomes. Additionally, TalarMade offers clinical services within the NHS, conducting specialist assessments and treatments for musculoskeletal conditions across several clinics nationwide.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in the UK is characterized by a growing demand for innovative medical devices and clinical solutions. With an increasing aging population and heightened awareness of health issues, there is a r
Similar Deals
Growth Lending → A & R Care Limited
2025
Foresight Group → Functional Gut Group
2025
NorthEdge → RoukenBio
2024
Fort Aggregator LP and The Prudential Assurance Company Limited → 4basebio PLC
2024
Marlin Equity Partners → Radar Healthcare
2024
N4 Partners → NeuroClin
2024
Rockpool
invested in
TalarMade
in 2024
in a Growth Equity & Expansion Capital deal